Website and social media enquiries

For all website and social media enquiries

Suzanne Bailey (Monday - Thursday)
T: 01923 779555
E: suzanne@cureparkinsons.org.uk

Lottie Smart (Friday)
T: 020 7487 3892
E: lottie@cureparkinsons.org.uk

Latest

Tom is Honoured at the World Parkinson Congress

Tom Isaacs, president of The Cure Parkinson's Trust, received an inaugural honour at the World Parkinson Congress in Portland Oregon today - for dedication and outstanding contribution in his work for the Parkinson's community.
The World Parkinson Congress 2016

The World Parkinson Congress is taking place this week providing an international forum for dialogue on the latest scientific discoveries, medical practices and caregiver initiatives related to Parkinson’s disease (PD). This year it is in Portland, Oregon.
CPT in Tatler UK!

October Edition of Tatler UK out now! Featuring CPT supporter Philip Lowe’s adventures in the Norwegian mountains!
James Parkinson – The Shaking Palsy 1817 - 200 Years of Progress

This meeting is being held to celebrate 200 years of progress in understanding the signs and symptoms of Parkinson’s disease, the cause of the illness and its treatment and progress towards a cure.

Related

Most read

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Apply for Funding
Trials - Repurposed drugs

Our Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop, or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Oxidative Stress and Inflammation in Parkinson's
CPT Collaborates to Assess the Clinical Use of Nilotinib in Parkinson's

The Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust announced plans to collaborate on the clinical development of nilotinib in preliminary studies as a treatment for Parkinson’s.
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?

A research paper recently published in the Journal of Parkinson's Disease discusses an impending clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells.
Our story
The NAC Trial - the facts
2016 Annual Review

Our 2016 Annual Review is here! We reflect on another full and productive year. Whilst there is more we can do, and indeed must do, we are proud of our achievements over the past year.
European Commission approves ONGENTYS® (opicapone)

BIAL announced that its product ONGENTYS® (opicapone) for Parkinsons is approved by the European Commission. ONGENTYS® will be available for people with Parkinson’s across Europe in 2016/17

Tag cloud

Alex Flynn alpha synuclein codicil Cure diagnostic direct debit flowers fundraising GDNF Leicestershire Country Cricket mitochondrial function parkinsons Parkinson's placebo present Sense Park

Parkinson's Movement

Alpha-synuclein and Parkinson's

Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?

A research paper recently published in the Journal of Parkinson's Disease discusses an impending clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells. Read more

Oxidative Stress and Inflammation in Parkinson's